Decatur Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-99,191
Closed -$7.74M 65
2020
Q4
$7.74M Sell
99,191
-2,175
-2% -$166K 1.42% 20
2020
Q3
$8.02M Buy
101,366
+18,634
+23% +$1.46M 1.58% 15
2020
Q2
$6.11M Buy
82,732
+7
+0% +$527 1.62% 17
2020
Q1
$6.07M Sell
82,725
-21,117
-20% -$1.66M 2.03% 10
2019
Q4
$9.01M Buy
+103,842
New +$8.53M 2.06% 9
2015
Q2
Sell
-249,728
Closed -$13.7M 99
2015
Q1
$13.7M Sell
249,728
-66,234
-21% -$3.75M 1.7% 29
2014
Q4
$17.1M Buy
315,962
+151,347
+92% +$8.43M 2.29% 17
2014
Q3
$9.31M Buy
164,615
+32,855
+25% +$1.84M 1.56% 30
2014
Q2
$7.27M Buy
+131,760
New +$7.19M 1.37% 31
2013
Q3
Sell
-5,397
Closed -$239K 112
2013
Q2
$239K Buy
+5,397
New +$241K 0.08% 89

Other funds holding MRK

Decatur Capital Management's MRK Position: Q1 2021 in Review

Decatur Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 99,191 shares — an estimated $7.74M sold.

Decatur Capital Management first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $17.1M in Q4 2014. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Decatur Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Decatur Capital Management sold 99,191 Merck shares in Q1 2021, an estimated $7.74M.
  • Decatur Capital Management first reported a position in Merck in Q2 2013 and held it in 10 quarters.
  • Decatur Capital Management's Merck position peaked at $17.1M in Q4 2014.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Decatur Capital Management's 13F filing for Q1 2021, filed 6 May 2021.